Plasma Cell-Free DNA and Caspase-3 Levels in Patients with Chronic Kidney Disease

被引:0
作者
Clementi, Anna [1 ,2 ]
Virzi, Grazia Maria [2 ,3 ]
Manani, Sabrina Milan [2 ,3 ]
de Cal, Massimo [2 ,3 ]
Battaglia, Giovanni Giorgio
Ronco, Claudio [3 ]
Zanella, Monica [2 ,3 ]
机构
[1] Santa Marta & Santa Venera Hosp, Dept Nephrol & Dialysis, I-95024 Acireale, Italy
[2] IRRIV Int Renal Res Inst, I-36100 Vicenza, Italy
[3] St Bortolo Hosp, Dept Nephrol Dialysis & Transplant, I-36100 Vicenza, Italy
关键词
cell free DNA; caspase-3; chronic kidney disease; HEMODIALYSIS; APOPTOSIS;
D O I
10.3390/jcm12175616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cell-free plasma DNA (cfDNA) is circulating extracellular DNA arising from cell death mechanisms (apoptosis, necrosis, etc.). It is commonly existent in healthy individuals, but its ranks increase in diverse clinical circumstances, such as kidney disease, sepsis, myocardial infarction, trauma and cancer. In patients with advanced chronic kidney disease, cfDNA is connected to inflammation, and it has been associated with higher mortality. Caspase-3 plays a dominant role in apoptosis, a mechanism of programmed cell death involved in the pathogenesis and progression of chronic kidney disease (CKD). The aim of this pilot study was the evaluation of cfDNA levels and caspase-3 concentrations in patients with chronic kidney disease, in order to investigate the potential role of these molecules, deriving from inflammatory and apoptotic mechanisms, in the progression of renal damage. Methods: We compared cfDNA and caspase-3 levels in 25 CKD patients and in 10 healthy subjects, evaluating their levels based on CKD stage. We also explored correlations between cfDNA and caspase-3 levels in CKD patients and between cfDNA and caspase-3 levels and serum creatinine and urea in this population. Results: We observed that cfDNA and caspase-3 levels were higher in patients with CKD compared to healthy subjects, in particular in patients with advanced renal disease (CKD stage 5). A positive correlation between cfDNA and caspase-3 levels and between cfDNA and caspase-3 and creatinine and urea were also noticed. Conclusions: Patients with chronic kidney disease show higher levels of cfDNA and caspase-3 levels compared to the control group. Based on these preliminary results, we speculated that the worsening of renal damage and the increase in uremic toxin concentration could be associated with higher levels of cfDNA and caspase-3 levels, thus reflecting the potential role of inflammation and apoptosis in the progression of CKD. Future studies should focus on the validation of these promising preliminary results.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Analysing cell-free plasma DNA and SLE disease activity
    Atamaniuk, Johanna
    Hsiao, Yu-Yang
    Mustak, Monika
    Bernhard, Duhm
    Erlacher, Ludwig
    Fodinger, Manuela
    Tiran, Beate
    Stuhlmeier, Karl M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (06) : 579 - 583
  • [22] Quantification of plasma cell-free DNA levels in dogs with various tumors
    Tagawa, Michihito
    Shimbo, Genya
    Inokuma, Hisashi
    Miyahara, Kazuro
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2019, 31 (06) : 836 - 843
  • [23] Cell-free DNA levels in acute myocardial infarction patients during hospitalization
    Destouni, Aspasia
    Vrettou, Christina
    Antonatos, Dionisis
    Chouliaras, George
    Traeger-Synodinos, Joanne
    Patsilinakos, Sotiris
    Kitsiou-Tzeli, Sophia
    Tsigas, Dimitrios
    Kanavakis, Emmanouel
    ACTA CARDIOLOGICA, 2009, 64 (01) : 51 - 57
  • [24] Immunoregulatory properties of cell-free DNA in plasma of celiac disease patients - A pilot study
    Brynychova, Iva
    Zinkova, Alzbeta
    Hoffmanova, Iva
    Korabecna, Marie
    Dankova, Pavlina
    AUTOIMMUNITY, 2019, 52 (02) : 88 - 94
  • [25] Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease
    Schmidt, Bernd
    Weickmann, Sabine
    Witt, Christian
    Fleischhacker, Michael
    CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V, 2008, 1137 : 207 - 213
  • [26] Prognostic implications of plasma myoglobin levels in patients with chronic kidney disease
    Lenglet, Aurelie
    Liabeuf, Sophie
    Desjardins, Lucie
    Neirynck, Nathalie
    Glorieux, Griet
    Lemke, Horst-Dieter
    Vanholder, Raymond
    Brazier, Michel
    Choukroun, Gabriel
    Massy, Ziad A.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2012, 35 (11) : 959 - 968
  • [27] Comparison of Plasma Cell-Free DNA Levels with Gene Expression Profiles of Peripheral Blood Cells During Haemodialysis
    Horinek, Ales
    Panczak, Ales
    Mokrejsova, Magdalena
    Rocinova, Katarina
    Korabecna, Marie
    Cerny, Dalibor
    Tesar, Vladimir
    CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM, 2011, : 159 - 163
  • [28] The Value of Serum Cell-Free DNA Levels in Patients With Schizophrenia
    Chen, Ling-yun
    Qi, Jing
    Xu, Hong-lei
    Lin, Xiang-yun
    Sun, Ya-jun
    Ju, Shao-qing
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [29] The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1
    Virzi, Grazia Maria
    Clementi, Anna
    Manani, Sabrina Milan
    Castellani, Chiara
    Battaglia, Giovanni Giorgio
    Angelini, Annalisa
    Vescovo, Giorgio
    Ronco, Claudio
    CARDIORENAL MEDICINE, 2021, 11 (5-6) : 218 - 225
  • [30] The value of plasma cell-free DNA levels as biomarker in patients with eating disorders: A preliminary study
    Verebi, Camille
    Nectoux, Juliette
    Duriez, Philibert
    Gorwood, Philip
    Ramoz, Nicolas
    Bienvenu, Thierry
    PSYCHONEUROENDOCRINOLOGY, 2024, 160